Exact Therapeutics AS (OSL:EXTX) Beginning Cash Position : kr39.12 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Beginning Cash Position?

Exact Therapeutics AS's Beginning Cash Position for the quarter that ended in Dec. 2023 was kr39.12 Mil.

Exact Therapeutics AS's quarterly Beginning Cash Position increased from Dec. 2022 (kr58.03 Mil) to Jun. 2023 (kr69.39 Mil) but then declined from Jun. 2023 (kr69.39 Mil) to Dec. 2023 (kr39.12 Mil).

Exact Therapeutics AS's annual Beginning Cash Position declined from Dec. 2021 (kr139.22 Mil) to Dec. 2022 (kr82.91 Mil) and declined from Dec. 2022 (kr82.91 Mil) to Dec. 2023 (kr69.39 Mil).

Exact Therapeutics AS Beginning Cash Position Historical Data

The historical data trend for Exact Therapeutics AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Beginning Cash Position Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

59.21

23.75

139.22

82.91

69.39

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial						107.26	103.69	58.03	69.39	39.12

Exact Therapeutics AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Exact Therapeutics AS Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines